Social Rocket
On 1 October 2026, Ro launched an unusual US campaign for its prescription product Ro Sparks: Megan Fox doesn't just advertise the product – she plays the product herself. The actress appears in a red suit with the brand logo. The appearance runs on streaming services, on television, on social media and as out-of-home advertising in New York and Los Angeles. For marketing teams, the staging is what matters most: a hard-to-explain offering becomes a character that is instantly recognisable on every channel.
One face for hundreds of ad assets
According to Marketing Daily, Ro is relying on four TV versions within two months and hundreds of paid social assets. The rollout began on Paramount+ and Peacock, among others; sports broadcasts, billboard space and the New York subway are also part of the media plan. In New York, a total of 20 tear-off posters were also planned across 1.000 locations. Anyone who takes one literally carries the advertising figure further out of the public space.
This means the campaign works not only as a classic celebrity spot. It has a simple visual system: the same character, the same colour, a recognisable appearance in 30 seconds of moving image just as on a poster or in the social feed. Ro produces the creative and buys digital media itself; Tatari supports the TV and connected TV buying.
The official Ro campaign page extends this character to the online entry point into the telehealth offering. In this way, attention, brand recognition and a concrete next digital step are linked together.
Why Ro doesn't show the celebrity as a patient
Many testimonials are meant to prove that a product works in the everyday life of a well-known person. Ro reverses the principle: Fox embodies the brand product without claiming to use it herself. The company also works with well-known personalities such as Serena Williams and Charles Barkley, although their appearances are set up differently.
This choice of role is the real creative twist. A sensitive health topic becomes a pop-culture staging without the famous person having to appear as a patient. Ro co-founder Saman Rahmanian told MediaPost that the campaign is meant to bring the topic into the shows and feeds where people already talk about intimacy.
In brand management, this resembles working with famous figures in other industries, but the tone is more conspicuous: humour and self-irony replace the usual clinical setting. Another healthcare campaign with a strong pop-culture motif is Noom's horror film on weight regain. Both examples show how health brands compete for attention in entertainment environments.
For advertising in Germany, a clear line applies here
What is promoted large-scale as a US campaign cannot simply be adopted in Germany. Section 10 of the German Heilmittelwerbegesetz (HWG, Medicines Advertising Act) prohibits advertising for prescription medicines aimed at the general public. The EU Medicinal Products Directive, Article 88, also provides for a corresponding ban. In the US, direct-to-consumer prescription drug advertising is by contrast permitted subject to regulatory requirements; the FDA explains the rules for broadcast ads.
Important for classifying this specific case: Ro describes Sparks as an individually manufactured combination product containing sildenafil and tadalafil. The official product information explicitly notes that Ro Sparks itself has no FDA approval. This article assesses the campaign, not the medical advertising claims.
For German teams, the transferable part therefore lies in the creative and the channel mix – not in direct product advertising. How differently the rules can play out is also shown by Google's US test of prescription drug ads in AI answers.
What marketers can take from the campaign
Ro turns an advertising face into a consistent campaign figure, spreads the same idea across paid social, streaming, TV and physical spaces, and directs interested people to a dedicated digital destination. That combination is what makes it interesting: a recognisable idea can carry many formats instead of needing a new message for every channel.
Ro has not yet published reliable result figures showing whether the campaign has brought in more new customers. What is visible, however, is how consistently the US brand combines creative recognisability with media delivery. In healthcare communication, checking every visual and every claim remains central – a topic that also illustrates Opella's automated creative approvals.
Sources: Ro: campaign page, MediaPost: conversation with Ro management, ADWEEK: initial report, FDA: advertising rules, HWG §10.